同方股份(600100.SH):清華控股轉讓21%的股份予中核資本 已完成過户登記手續
格隆匯1月9日丨同方股份(600100.SH)公佈,公司於2020年1月8日收到控股股東中國核工業集團資本控股有限公司(“中核資本”)發來的通知及《中國證券登記結算有限責任公司過户登記確認書》,清華控股有限公司(“清華控股”)將持有的約6.2242億股公司股票(佔公司總股本的21%)轉讓給中核資本的過户登記手續已於2020年1月7日辦理完畢。
此次股份轉讓過户完成後,中核資本仍為公司的控股股東,公司實際控制人仍為國務院國資委。同時,根據《表決權委託協議》的約定,2019年12月31日清華控股委託給中核資本的21%股份對應的表決權委託終止。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.